Search

Your search keyword '"Dysmenorrhea"' showing total 244 results
Start Over Descriptor "Dysmenorrhea" Publication Type News
244 results on '"Dysmenorrhea"'

11. Dysmenorrhea

Subjects
Self-care, Health, Dysmenorrhea, Sleep, Health
Abstract

Description The medical name for menstrual cramps, which are throbbing or cramping pains in the lower stomach area that can happen before and during periods. Self-care Get enough sleep and [...]

Published
2024

14. Researchers from Babol University of Medical Sciences Provide Details of New Studies and Findings in the Area of Dysmenorrhea (The Effect of Rosa Foetida Extract along with Self-Care Education on Primary Dysmenorrhea: A Prospective Randomized ...)

Subjects
Self-care, Health, Clinical trials, Dysmenorrhea, Health
Abstract

2024 FEB 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on dysmenorrhea have been published. According to news reporting originating [...]

Published
2024

19. Dare Bioscience Announces Start of a Phase 1 Study for its Potential First-in-Category Treatment for Primary Dysmenorrhea, DARE-PDM1

Subjects
Biotechnology industry -- Market research -- Product development, Governmental investigations, Dysmenorrhea, Anti-inflammatory drugs, Marketing research, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced the start of a Phase 1 study evaluating its [...]

Published
2023

20. Dare Bioscience Announces Start of a Phase 1 Study for its Potential First-in-Category Treatment for Primary Dysmenorrhea, DARE-PDM1

Subjects
Biotechnology industry -- Market research -- Product development, Dysmenorrhea, Anti-inflammatory drugs, Marketing research, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Dare Bioscience, Inc. has issued the following news release: Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced the start of a Phase 1 [...]

Published
2023

21. Dare Bioscience Announces New Development Program, DARE-PDM1, as a Potential First-in-Category Treatment for Primary Dysmenorrhea

Subjects
United States. Food and Drug Administration, Biotechnology, Biotechnology industry, Drug approval, Dysmenorrhea, Anti-inflammatory drugs, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Dare Bioscience, Inc. has issued the following news release: Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced a new development program targeted at [...]

Published
2022

24. India's first clinical trial for menstrual cramps using cannabis-based medicines

Subjects
Marijuana -- Product development, Menstruation, Clinical trials, Dysmenorrhea, Biotechnology industry
Abstract

HempStreet to initiate clinical trials for menstrual cramps in collaboration with Amrita School of Ayurveda New Delhi-based startup HempStreet is conducting a year-long clinical trials to help women suffering from [...]

Published
2022

25. 6 Ways to Ease Painful Menstrual Cramps

Subjects
Menstruation, Dysmenorrhea, Mediation, News, opinion and commentary, Sports and fitness
Abstract

Vaginas are great, but the worst part about having one is, without a doubt, menstrual cramps. Menstrual cramps are extremely common among women, with 84.1% of women reporting experiencing menstrual [...]

Published
2022

28. Men left 'hollering' in period pain after trying menstruation simulators; Participants howl in agony after being given menstrual cramps, with one saying: 'I never want to experience that again'

Subjects
Menstruation, Dysmenorrhea, General interest, News, opinion and commentary
Abstract

Byline: Jonny Bentley Men in the Indian state of Kerala were left 'hollering' in pain after experiencing period pains as part of an experiment to normalise menstrual discussion within the [...]

Published
2022

30. Menstrual cramps derail Chinese teen's French Open dream in loss to Swiatek

Subjects
Menstruation, Teenagers, Youth, Dysmenorrhea, General interest, News, opinion and commentary
Abstract

Byline: Story by Reuters (CNN) -- Chinese teenager Zheng Qinwen suffered with menstrual cramps as she lost to Poland's Iga Swiatek in the French Open fourth round on Monday after [...]

Published
2022

33. Menstrual cycle impacts two-thirds of female rugby internationals; EXCLUSIVE

Subjects
Rugby football -- Research, Menstruation -- Research, Athletes, Dysmenorrhea, General interest
Abstract

Byline: Kate Rowan Female international rugby players say their athletic performance has been negatively affected due to menstrualcycle symptoms, according to a recent ground-breaking study. Researchers from the University of [...]

Published
2020

38. HempStreet launches cannabis-based medicine for menstrual cramps

Subjects
Medical marijuana, Menstruation, Dysmenorrhea, Business, international
Abstract

In its endeavor to offer a sustainable, herbal and ayurvedic solution for menstrual cramps, India's first research to retail venture in the Ayurvedic Cannabis (Bhang) sector, HempStreet recently launched the [...]

Published
2020

39. Medicinal cannabis for relief from menstrual cramps

Subjects
Medical marijuana, Menstruation, Dysmenorrhea, Business, international, Law
Abstract

As per a study published in the 'British Medical Journal', menstrual pain, heavy bleeding, and low mood may be linked to nearly nine days of lost productivity per woman every [...]

Published
2020

40. ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis

Subjects
Endometriosis -- Care and treatment, Hormone antagonists, Gonadotropins, Estrogens, Hormones, Infertility, Pituitary hormones, Dysmenorrhea, Phenols (Class of compounds), Reproductive health, Novels, Business, international, Law
Abstract

(GlobeNewswire) - GENEVA, Switzerland and BOSTON, MA (June 4, 2020) ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today [...]

Published
2020

41. ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis

Subjects
Pituitary hormones, Silodosin, Estrogens, Endometriosis -- Drug therapy, Hormone antagonists, Gonadotropins, Hormones, Women's health, Dysmenorrhea, Phenols (Class of compounds), Reproductive health, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- GENEVA, Switzerland and BOSTON, MA (June 4, 2020) - ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve [...]

Published
2020

42. UWS study explores impact of menstruation on elite sport

Subjects
Menstruation -- Research, Athletes, Dysmenorrhea, Rugby football, Business, international
Abstract

London: University of the West of Scotland, UK Government has issued the following news release: A first-of-its-kind study by researchers at University of the West of Scotland (UWS) has explored [...]

Published
2020

43. Menstrual cycle affects two-thirds of female rugby internationals, research shows; Exclusive: It is the first time that a study of this kind has been conducted-not just for rugby players, but for team sports generally

Subjects
Rugby football -- Research, Menstruation -- Research, Time, Athletes, Dysmenorrhea, General interest, News, opinion and commentary
Abstract

Byline: Kate Rowan Female international rugby players say their athletic performance has been negatively affected due to menstrual cycle symptoms, according to a recent groundbreaking study. Researchers from the University [...]

Published
2020

44. Pipeline Review for Endometriosis - H1 2020

Subjects
Chugai Pharmaceutical Company Ltd., Oral contraceptives, Endometriosis, Anti-inflammatory agents, Pelvic pain, Birth control, Infertility, Dysmenorrhea, Infection, Diseases, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Endometriosis - Pipeline Review, H1 2020' drug pipelines has been added to ResearchAndMarkets.com's offering. This latest Pharmaceutical and Healthcare [...]

Published
2020

45. Pipeline Review for Endometriosis - H1 2020 - ResearchAndMarkets.com

Subjects
Chugai Pharmaceutical Company Ltd., Oral contraceptives, Pharmaceutical industry, Endometriosis, Anti-inflammatory agents, Pelvic pain, Birth control, Infertility, Dysmenorrhea, Infection, Progestational hormones, Diseases, Sex hormones, Business, Business, international
Abstract

DUBLIN -- The 'Endometriosis - Pipeline Review, H1 2020' drug pipelines has been added to ResearchAndMarkets.com's offering. This latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis - Pipeline Review, H1 [...]

Published
2020

46. Pipeline Review for Endometriosis - H1 2020

Subjects
Chugai Pharmaceutical Company Ltd., Pharmaceutical industry, Endometriosis, Pelvic pain, Infertility, Dysmenorrhea, Infection, Diseases, Business, Business, international
Abstract

M2 PRESSWIRE-May 12, 2020-: Pipeline Review for Endometriosis - H1 2020 (C)1994-2020 M2 COMMUNICATIONS RDATE:12052020 The 'Endometriosis - Pipeline Review, H1 2020' drug pipelines has been added to ResearchAndMarkets.com's offering. [...]

Published
2020

48. Dysmenorrhea Treatment Market Global Analysis with Size, Share, Upcoming Trends, Demand, Dynamics, Opportunities and Strong Growth in Future 2025

Subjects
Pfizer Inc. -- Market research -- Forecasts and trends -- Growth, Market research, Pharmaceutical industry -- Market research -- Forecasts and trends -- Statistics -- Growth, Dysmenorrhea, Menstruation, Profits, Company growth, Marketing research, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 19, 2019-: Dysmenorrhea Treatment Market Global Analysis with Size, Share, Upcoming Trends, Demand, Dynamics, Opportunities and Strong Growth in Future 2025 (C)1994-2019 M2 COMMUNICATIONS RDATE:18122019 Acknowledging the Exponential [...]

Published
2019

49. Can a desert plant help treat Endometriosis?

Subjects
Endometriosis, Infertility, Dysmenorrhea, Business, international
Abstract

TEHRAN- A new study has investigated the effects of Escanbil, a desert plant, in treating Endometriosis, Royan Research Institute reported. Endometriosis is a chronic, gynecological condition where tissue from the [...]

Published
2019

50. Cannabis has great medical potential. But don't fall for the CBD scam; The UK market for cannabidiol (CBD), a compound of cannabis, will soon be worth £1bn. But consumers are being conned

Subjects
Marijuana, Skin care, Pets, Addiction, Dysmenorrhea, Phenols (Class of compounds), Epilepsy, Post-traumatic stress disorder, Dementia, Menstruation, Skin, Sales management, Arthritis, Alzheimer's disease, Insomnia, News, opinion and commentary
Abstract

Byline: Mike Power Roll up, roll up, ladies and gentleman, and gather around. Do you, your loved one -- or family pet -- suffer from any of the following conditions? [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results